Minnesota SF2645 amends health-related statutes to allow Formulary Committee members with potential conflicts of interest to participate in committee.
Minnesota SF2645 modifies the operations of the Formulary Committee by permitting members with potential conflicts of interest to participate in committee communications and discussions, provided they recuse themselves from related votes. The bill also requires the commissioner of human services to establish a public comment process for Formulary Committee recommendations.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.